Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P O Anderson

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Hospital Pharmacy|April 1, 1984
Lean body mass and volume of distributionP O Anderson, J R Lane
DICP : the Annals of Pharmacotherapy|July 1, 1989
Neonatal alprazolam withdrawal--possible effects of breast feedingP O Anderson, G G McGuire
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|November 1, 1993
Clinical advances in the management of severe nausea and vomiting during pregnancyV Newman, J T Fullerton, P O Anderson
Clinical Pharmacy|October 1, 1987
Evaluation of prenatal vitamin-mineral supplementsV Newman, R B Lyon, P O Anderson
Drug Intelligence & Clinical Pharmacy|February 1, 1981
New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme)H L Macfie, C L Colvin, P O Anderson
The Journal of Emergency Medicine|April 16, 1998
A close look at fenfluramine and dexfenfluramineL E Vivero, P O Anderson, R F Clark
The Journal of Emergency Medicine|November 1, 1995
Meperidine: therapeutic use and toxicityR F Clark, E M Wei, P O Anderson
Contemporary Pharmacy Practice|January 6, 1983
The clinical pharmacist as a member of the burn teamP O Anderson, T L Wachtel, H A Frank, et al.
International Immunopharmacology|May 19, 2001
Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligandsP Wang, P O Anderson, S Chen, et al.
International Immunology|July 27, 2001
Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell linesK M Paulsson, P Wang, P O Anderson, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Hospital Pharmacy|April 1, 1984
Lean body mass and volume of distributionP O Anderson, J R Lane
DICP : the Annals of Pharmacotherapy|July 1, 1989
Neonatal alprazolam withdrawal--possible effects of breast feedingP O Anderson, G G McGuire
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|November 1, 1993
Clinical advances in the management of severe nausea and vomiting during pregnancyV Newman, J T Fullerton, P O Anderson
Clinical Pharmacy|October 1, 1987
Evaluation of prenatal vitamin-mineral supplementsV Newman, R B Lyon, P O Anderson
Drug Intelligence & Clinical Pharmacy|February 1, 1981
New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme)H L Macfie, C L Colvin, P O Anderson
The Journal of Emergency Medicine|April 16, 1998
A close look at fenfluramine and dexfenfluramineL E Vivero, P O Anderson, R F Clark
The Journal of Emergency Medicine|November 1, 1995
Meperidine: therapeutic use and toxicityR F Clark, E M Wei, P O Anderson
Contemporary Pharmacy Practice|January 6, 1983
The clinical pharmacist as a member of the burn teamP O Anderson, T L Wachtel, H A Frank, et al.
International Immunopharmacology|May 19, 2001
Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligandsP Wang, P O Anderson, S Chen, et al.
International Immunology|July 27, 2001
Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell linesK M Paulsson, P Wang, P O Anderson, et al.
Pageof 4